Helping you navigate challenges
As a trusted immunology partner, we have a proven track record of bringing therapies—like IL inhibitors, JAK inhibitors, biosimilars, and rare autoimmune treatments—to market across multiple indications.
From early-stage pipeline strategy to post-launch optimization, we guide clients with scientific rigor and a deep understanding of immunology’s evolving access environment. Our strategies and communications address indication expansion, specialty pharmacy distribution, and cross-specialty prescribing—helping brands navigate access challenges.
Our Expertise & Our People
Our immunology expertise is built on regulatory, clinical, and market access depth.
Our team includes former access decision makers, medical directors, pricing experts, and commercial strategists with deep experience in immunology. We extend our perspective through a curated network of specialists across dermatology, gastroenterology, and rheumatology—providing real-time insights into evolving care standards and access expectations. With integrated capabilities, we deliver tailored solutions that unlock value and improve patient access.
Our Values In Action
Mental Health Awareness Month: Advancing Access to Long-Acting Medications
Maureen Hennessey, Ph.D. | SVP, Director, Value Transformation Christopher Terrone | VP, Healthcare Insights, Market...
